evidenced base
Tinacherry100$
WK9Assigncherryt.pptxPart 5: Recommending an Evidence-Based Practice Change
Tina cherry
Walden university
Nurs 6052: essentials of evidence-based practice
Dr. south
August 2, 2020
Healthcare Organization
My healthcare organization is a psychiatric facility offering various types of mental healthcare services.
It is a private and non-profit making care facility equipped with over 80 care providers serving in various sub-specialties.
The facility employees work under the spirit of servant leadership to provide for the needs of the patients.
Collaboration between members of the staff is highly encouraged at every level.
A cultural change is embraced through a change initiative rooted in the values, beliefs and behaviors of the members of the facility.
Current Problem or Opportunity for Change
The problem my organization is facing is the management of psychiatric mental health.
Medical practitioners and care providers face a challenge of diagnosing and treatment of schizophrenia.
There are risks and benefits associated with the use of anti-psychotic medication.
Application of a multifaceted approach involving various factors would help in informing of the appropriate interventions that facilitate patient’s recovery.
It is important to adopt evidence-based practices to combat mental health disorders.
Current Problem or Opportunity for Change
Management of psychiatric mental health issues such as schizophrenia involves various stakeholders such as hospital facility management, patients, psychiatrists and the families of the patients.
Hospital management will fund the program while psychiatrists will be tasked with the role of implementing interventions and educating the clients and their families concerning the patient’s wellbeing.
The risks involved with the change implementation include inadequate support from the multidisciplinary healthcare teams and management, inadequate funds and continued practice of ineffective management of mental health disorders.
Evidence-based Idea for Change
There are various strategies of management and treatment of mental health disorders in a psychiatric facility. The risks and benefits of anti-psychotic medication should be analyzed before they are utilized in treatment.
It is necessary to assess the medical side effects of the antipsychotic medications because they influence medication adherence and quality of life (Endriyani et al., 2018).
According to Constantine et al. (2015), there are challenges of discontinuing antipsychotic medication, and thus, clinicians should have adequate trials of evidence-based treatments before responding to patients especially with schizophrenia.
Evidence-based Idea for Change
Patients receiving antipsychotic medication in the psychiatric facility should be continually monitored.
There is a need for clear guidelines, monitoring protocol and education of general practitioners on the requirements of monitoring psychiatric patients (Keenan et al., 2020).
Besides, a right treatment model for the patients should be developed informed by heterogeneity and clinical research (Potkin et al., 2020).
Psychiatric disorders can also be managed through quality improvement as an intervention.
Plan for Knowledge Transfer of the Change
According to Straus, Tetroe & Graham (2009), knowledge transfer strengthens healthcare framework and improve the delivery of healthcare services.
Knowledge creation will involve carrying out scientific findings from different websites, journals and articles.
The dissemination of knowledge will be aided by utilization of various technologies used in the organization for communication, for instance, portals and posters.
Inter-departmental meetings will also be effective to discuss the proposed project.
The organization will then adopt the proposal when the management accepts it and necessary resources are gathered for the project.
Implementation of knowledge will then occur when the change in practice is effected in the management of psychiatric disorders.
Measurable Outcomes
With the implementation of the evidence-based change, the following are anticipated during assessment:
Stabilization of patients with mental health disorders after treatment with antipsychotic medication within a month.
Increase in compliance with antipsychotic medication.
Symptoms remission and improve in the quality of life of patients.
Increased in monitoring for patients under antipsychotic medication by healthcare practitioners.
A summary of the peer-reviewed articles used
Phahladira et al. (2020), found out that “symptom remission is not a prerequisite for functional remission and a good quality of life.”
According to Endriyani et al. (2018), there is a need to assess side-effects of antipsychotic medications because they have effects on medical adherence and quality of life.
Potkin et al. (2020)suggested that clinical research and heterogeneity should inform the clinical trials designs for new treatment of treatment-resistant schizophrenia.
A monitoring protocol should be designed to guide nurses in monitoring patients receiving antipsychotic treatment in a psychiatric facility (Keenan et al., 2020).
Lesson Learned
There are various research methods utilized in collecting data for the research.
The evidence level of the research studies were level II and I.
Each research study has unique research questions forming the objectives of the study.
There are unique limitations of each research that hinders the general application of results.
References
Constantine, R. J., Andel, R., McPherson, M., & Tandon, R. (2015). The risks and benefits of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: A randomized controlled trial. Schizophrenia Research, 166(1–3), 194–200. https://doi.org/10.1016/j.schres.2015.05.038
Endriyani, L., Chien, C., Huang, X., & Chieh‐Yu, L. (2018). The influence of adherence to antipsychotics medication on the quality of life among patients with schizophrenia in Indonesia. Perspectives in Psychiatric Care, 55(2), 147–152. https://doi.org/10.1111/ppc.12276
Keenan, R., Chepulis, L., Ly, J., Carter, S., Lao, C., Asim, M., Bhat, A., Deo, S., Lim, K. P., Mohammed, R., Scarlet, S., & Lawrenson, R. (2020). Metabolic screening in primary care for patients with schizophrenia or schizoaffective disorder and taking antipsychotic medication. Journal of Primary Health Care, 12(1), 29–34. https://doi.org/10.1071/HC19023
Phahladira, L., Luckhoff, H. K., Asmal, L., Kilian, S., Scheffler, F., Plessis, S. du, Chiliza, B., & Emsley, R. (2020). Early recovery in the first 24 months of treatment in first-episode schizophrenia-spectrum disorders. Npj Schizophrenia, 6(1). https://doi.org/10.1038/s41537-019-0091-y
Potkin, S. G., Kane, J. M., Correll, C. U., Lindenmayer, J.-P., Agid, O., Marder, S. R., Olfson, M., & Howes, O. D. (2020). The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research. Npj Schizophrenia, 6(1), 1–10. https://doi.org/10.1038/s41537-019-0090-z
